Redline Pharmacy Recalls Acetylcysteine Ophthalmic Solution Due to Processing Controls
Redline Pharmacy Solutions is recalling Acetylcysteine Ophthalmic 10% Solution due to a lack of processing controls. The product was sold to patients in Nebraska.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a temporary or medically reversible adverse health consequence. The source text cites 'Lack Of Processing Controls' as the reason, which is a quality control issue rather than a specific high-risk pathogen or structural defect, fitting the Moderate severity criteria for voluntary precautionary or minor labeling/processing errors.
Plain-English summary
Redline Pharmacy Solutions is voluntarily recalling Acetylcysteine Ophthalmic 10% Solution, 5 mL per dropper bottle. The recall is being conducted because of a lack of processing controls during the manufacturing process.
The affected product is identified by Lot 02242020@1. The recall quantity is 2x5 ml bottles. The product was distributed to patients in Nebraska.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Acetylcysteine Ophthalmic 10% Solution, 5 mL per dropper bottle (10ML). Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901
- Manufacturer
- Redline Pharmacy Solutions
- Category
- Drug — Ophthalmic Solution
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 02242020@1
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 6 recalled by Redline Pharmacy Solutions under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Redline Pharmacy Solutions
See all →- SevereRedline Pharmacy Recalls Morphine Sulfate Due to Processing Control Deficiencies
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Morphine Sulfate Due to Processing Controls
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Ertapenem Injectable Due to Processing Control Issues
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Vancomycin Injectable Due to Processing Control Deficiencies
FDA (Drugs) · 2020-03-18
- ModerateRedline Pharmacy Recalls Daptomycin Injectable Due to Processing Control Issues
FDA (Drugs) · 2020-03-18
Same hazard · processing controls
See all →- HighCompounded tirzepatide 8.8 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 0.44 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded tirzepatide 4.4 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 0.22 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 1.5 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13